Multistakeholder perceptions of additional value elements for United States value assessment of health interventions

RB McQueen, A Inotai, A Zemplenyi, N Mendola… - Value in Health, 2024 - Elsevier
Objectives Limitations in conventional cost-effectiveness methods have led to calls for
incorporation of additional value elements in assessments of health technologies. However …

Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol

S Ngorsuraches, TC Lai, R Habermann… - PharmacoEconomics …, 2024 - Springer
Objective The engagement of patients and family caregivers in value assessment is pivotal
since they provide valuable contributions to assessment acceptability and relevance. The …

Comparative Effectiveness of Rare Disease Therapies Using Multi-Criteria Decision Analysis: A Case Example in Neuromyelitis Optica Spectrum Disorder

ND Mendola - 2024 - search.proquest.com
Abstract Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare neurological disease
where three newly approved therapies: eculizumab, satralizumab, and inebilizumab …

Multicriteria Decision Analysis and Value Assessment Frameworks: Where Do We Stand? What Next?

LP Garrison - Value in Health, 2024 - valueinhealthjournal.com
The 2018 report of the ISPOR Special Task Force (STF) on Value Assessment Frameworks
recommended that health technology assessment (HTA) in the United States should use …